Clinical validation of a multiplex droplet digital PCR for diagnosing suspected bloodstream infections in ICU practice: a promising diagnostic tool
Conclusions: The multiplexed ddPCR is a flexible and universal platform, which can be used as an add-on complementary to conventional BC. When combined with clinical infection evidence, ddPCR shows potential advantages for rapidly diagnosing suspected BSIs and AMR genes in ICU practice. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 5, 2022 Category: Consumer Health News Source Type: news
The Polio Threat Continues to Grow —But a New Vaccine Could Make a Difference
The recent return of polio has hit like something of an epidemiological thunderclap. It was in 1979 that polio was officially declared eradicated in the U.S.—an early step in a multi-generational effort to wipe out the disease around the world. On July 21, however, the New York State Department of Health announced a case of polio in an unvaccinated man in Rockland County, and since then, circulating poliovirus has been found in wastewater there and in neighboring Orange County, as well as in New York City. In London, the virus was also found in wastewater in February, and in Jerusalem, a case of the disease turned up...
Source: TIME: Health - August 31, 2022 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized healthscienceclimate Vaccines Source Type: news
Researchers in Boston Find COVID-19 Spike Protein Lingers in Long COVID-19 Patients
Viral reservoir could be behind persistence, says study, which also suggests a blood biomarker could be found for clinical laboratory testing Microbiologists and virologists working closely with physicians treating long COVID-19 patients will gain new insights in a study that found coronavirus spike protein in COVID-19 patients’ blood up to 12 months after diagnosis. The […]
The post Researchers in Boston Find COVID-19 Spike Protein Lingers in Long COVID-19 Patients appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - August 31, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory News Laboratory Pathology Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing Precision Medicine anatomic pathology antigens biomarkers Brigham and Women’s Hospital clinical laboratory cytokine Source Type: news
New Case of Polio Diagnosed in New York, Poliovirus Found in Wastewater in Two Counties
Experts say it is time ‘to restore our confidence in vaccines’ as many medical laboratories take steps to support testing for the polio virus Clinical laboratories and microbiologists in the state of New York will want to know that, in July, a man in New York was diagnosed with polio and subsequently the virus was […]
The post New Case of Polio Diagnosed in New York, Poliovirus Found in Wastewater in Two Counties appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - August 26, 2022 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: International Laboratory News Laboratory Pathology Laboratory Testing Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing anatomic pathology CDC centers for disease control and prevention clinical laboratory COVID-19 Dark Daily Source Type: news
Artificial sweeteners should 'not be assumed to be safe', scientist warns
Dr Eran Elinav, the microbiologist who led the Israeli study on 120 people, said: 'We should not assume [sweeteners] are safe until proven otherwise. Until then, caution is advised.' (Source: the Mail online | Health)
Source: the Mail online | Health - August 25, 2022 Category: Consumer Health News Source Type: news
‘People are freaking out, seeing young men with lesions all over their faces’: the anxious wait for monkeypox vaccines
With supplies running low, many gay and bisexual men are struggling to get appointments at sexual health centres – and for some, the handling of the outbreak has alarming echos of the HIV/Aids epidemicIn a waiting room at the Mortimer Market Centre, a sexual health clinic in central London, a slow but steady stream of men who have sex with men (MSM) are arriving to receive their first monkeypox vaccination. It is a sweltering afternoon, and all available slots have been filled, as they have ever since vaccines started to be delivered here in early July.Few know much about the monkeypox virus itself, or how the vaccine wo...
Source: Guardian Unlimited Science - August 25, 2022 Category: Science Authors: Michael Segalov Tags: Monkeypox Vaccines and immunisation Infectious diseases Medical research Microbiology LGBTQ rights Health Society NHS Source Type: news
Not drying your hands could be even worse than not washing them at all, expert claims
Dr David Webber, a microbiologist at private testing lab Microbial Innovations Limited in Ripley, Derbyshire, said people who do not dry their hands should 'stop and rethink'. (Source: the Mail online | Health)
Source: the Mail online | Health - August 24, 2022 Category: Consumer Health News Source Type: news
Your Doppelg änger Is Out There and You Probably Share DNA With Them
That person who looks just like you is not your twin, but if scientists compared your genomes, they might find a lot in common. (Source: NYT Health)
Source: NYT Health - August 23, 2022 Category: Consumer Health News Authors: Kate Golembiewski and Fran çois Brunelle Tags: Face Genetics and Heredity DNA (Deoxyribonucleic Acid) Twins Facial Recognition Software Photography Microbiology Forensic Science Research Cell Reports (Journal) Brunelle, Francois your-feed-science Source Type: news
First trial of antiviral monkeypox drug that could speed recovery begins in UK
Clinical trial will explore whether Tecovirimat can reduce time it takes for skin lesions and ulcers to healThe first clinical trial in patients with monkeypox of an antiviral drug that could speed their recovery has begun in the UK.The trial, known as Platinum, will explore whether Tecovirimat – a drug originally developed for smallpox – may reduce the length of time it takes for skin lesions and ulcers to heal.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 23, 2022 Category: Science Authors: Nicola Davis Science correspondent Tags: Monkeypox Medical research Infectious diseases Microbiology Science UK news World news Source Type: news
Matching Clostridioides difficile strains obtained from shoe soles of healthcare workers epidemiologically linked to patients and confirmed by whole-genome sequencing
Conclusions: HCWs ' shoe soles were positive in 17.8% with C. difficile strains linked epidemiologically and confirmed by WGS to infected patients suggesting potential transmission by HCWs ' shoe soles. This pilot study provides sufficient evidence to further evaluate this potential mode of healthcare-associated transmission of C. difficile by a larger clinical trial. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 19, 2022 Category: Consumer Health News Source Type: news
Thanks to Brexit, I lost a €2.5m research grant. I fear for the future of UK science | José R Penadés
In rejecting EU funding programmes, Britain has jeopardised research and made itself far less attractive to overseas scientistsIn March, I was given a great scientific opportunity: a €2.5m grant from the European Research Council (ERC) to study how disease-causing bacteria swap genes with each other to become more infective, or evade treatments such as antibiotics. The ERC advanced grant is a very prestigious award, and it meant that I and the scientists at my lab at Imperial College London could finally get to work on questions and experiments we had been planning for the past few years.But just a few weeks later I was ...
Source: Guardian Unlimited Science - August 18, 2022 Category: Science Authors: Jos é R Penadés Tags: Research funding Science policy Brexit European Union UK news Source Type: news
Clinical validation of a multiplex droplet digital PCR for diagnosing suspected bloodstream infections in ICU practice: a promising diagnostic tool
Conclusions: The multiplexed ddPCR is a flexible and universal platform, which can be used as an add-on complementary to conventional BC. When combined with clinical infection evidence, ddPCR shows potential advantages for rapidly diagnosing suspected BSIs and AMR genes in ICU practice. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 15, 2022 Category: Consumer Health News Source Type: news
Angela Rasmussen on Covid-19: ‘This origins discussion is the worst thing about Twitter’
Did Sars-CoV-2 emerge from a Huanan market stall or a lab? For the American virologist, who has been abused online for defending a ‘natural’ origin, the evidence is clearAngela Rasmussen studies the interactions between hosts and pathogens and how they shape disease. Before the pandemic, she worked on the emerging viruses that cause Middle East respiratory syndrome (Mers), Ebola, dengue and avian flu. Then, when Covid-19 erupted,the American virologist, who works at the University of Saskatchewan in Canada, was drawn into the debate over where it came from. She has beenamong the most vocal scientists on Twitter defendi...
Source: Guardian Unlimited Science - August 13, 2022 Category: Science Authors: Laura Spinney Tags: Coronavirus Infectious diseases Medical research Microbiology Science Culture Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Investor Update - August 12, 2022 Category: Pharmaceuticals Source Type: news
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of ageThe FDA also approved Xofluza to prevent influenza in children aged five years and older following contact with an infected personBasel, 12 August 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza ® (baloxavir marboxil) for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years o...
Source: Roche Media News - August 12, 2022 Category: Pharmaceuticals Source Type: news
